Factory CRO and Boston Biomedical Associates Announce Merger
07 January 2019
Kester Capital portfolio company, Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston Biomedical Associates (BBA) a premier full-service medical device/biotechnology CRO and consultancy based in the United States announce that they have merged.
The merger further advances the shared strategic vision to become the leading global medical device and medical technology focused CRO. Following the recent acquisitions of Five Corners, MileStone Research Organization and Clinical Device Group, the Factory-CRO Group now has specialized operations and expertise in the United States, Europe and Australia/New Zealand. This global expansion coupled with the diverse medical therapeutic expertise provides a means to efficiently service clients.
+44 203 747 5700
About Factory CRO
Factory-CRO Group is a leading, full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics and device-drug combination products internationally. Founded in 1992, the business offers a full suite of trial management services to its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, dermatology and aesthetics. Current members of Factory-CRO Group are: BBA, Five Corners CRO, Milestone Research group and Factory-CRO.
About Boston Biomedical Associates
Boston Biomedical Associates (BBA) is a premier full-service medical device/biotechnology CRO and consultancy firm. Founded in 2000, by Lauren Baker, Ph.D., BBA has earned a reputation for its comprehensive approach to clinical trial execution services for its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, endocrine and neurologic disorders.